The Boston University Clinical and Translational Science Institute (BU CTSI) is comprised of the BU Medical Campus (applicant), BU Charles River Campus, Boston Medical Center with its 15 Community Health Centers and Roger Williams Medical Center, in Providence, Rhode Island, along with partnerships with the Boston VAMC and Edith Norse Rogers Memorial Veterans Hospital. The Institute's vision centers on process improvement in providing resources and services, on game-changing disruptive innovations and on competency based team science education. Three highly interactive institute aims help create the most efficient system for clinical and translational research, develop creative scientific tools to expedite and retool traditional research processes, and train future translational scientists to do it. We will: 1) Create an Integrated Home for translational science that: A. integrates a pilot award program to target gaps in drug and device development;B. has a highly secure HIPAA compliant NIST-approved environment for data;C. contains efficiency measures for human subjects research;and D. incorporates new evaluation tools that assess processes and costs to be responsive to new opportunities and strategies. 2) Create an efficient delivery of Clinical and Translational Research Services to implement solutions that streamline and improve the quality, safety, efficiency and cost of clinical research. These include: A. skilld research personnel;B. an EMR-based Registry of ethnic populations;C. faster regulatory approval;D. consultative services for study design, biostatistics and bioinformatics;E. biobanking blood from our Registry for creation of iPS cells from normal subjects for drug toxicity screening;and F. creative tools to expedite and retool traditional research. 3) Create a Career Development Program for Future Scientists that: A. has a competency-based curriculum and evaluation approaches;B. supports a KL2 mentor based program in translational science;C. launches a new TL1 Program for supporting PhD scholars in translational science focused on regenerative medicine;D. provides mentor skill building tools to sustain high quality research mentoring;E. creates online self-directed modularized courses to enhance knowledge in informatics and other key translational research topics;F. implements an education evaluation plan and G. helps scientists with the downstream phase of commercialization of research. These associations and aims will support the mission of NCATS to change and speed the planning and implementation of clinical and translational research.

Public Health Relevance

Through an integrated home that builds upon institutional strengths, the mission of the BU CTSI is to catalyze the generation of innovative processes, methods and techniques that will enhance and speed the development, testing, and implementation of devices, diagnostics and therapeutics, across a wide range of human diseases and conditions. This will accelerate discoveries to improve the public health.

Agency
National Institute of Health (NIH)
Institute
National Center for Advancing Translational Sciences (NCATS)
Type
Specialized Center--Cooperative Agreements (U54)
Project #
3U54TR001012-01S1
Application #
8917346
Study Section
Special Emphasis Panel (ZAI1-PTM-C (S2))
Program Officer
Rosenblum, Daniel
Project Start
2014-08-20
Project End
2015-08-19
Budget Start
2014-09-10
Budget End
2015-03-09
Support Year
1
Fiscal Year
2014
Total Cost
$115,345
Indirect Cost
$44,884
Name
Boston University
Department
Type
Organized Research Units
DUNS #
604483045
City
Boston
State
MA
Country
United States
Zip Code
02118
Lin, Meng-Yun; Kressin, Nancy R; Paasche-Orlow, Michael K et al. (2018) Is 30-Day Posthospitalization Mortality Lower Among Racial/Ethnic Minorities?: A Reexamination. Med Care 56:665-672
Mirzakhani, Hooman; Carey, Vincent J; McElrath, Thomas F et al. (2018) The Association of Maternal Asthma and Early Pregnancy Vitamin D with Risk of Preeclampsia: An Observation From Vitamin D Antenatal Asthma Reduction Trial (VDAART). J Allergy Clin Immunol Pract 6:600-608.e2
Joshi, Priya P; Quintiliani, Lisa M; McCarthy, Ashley C et al. (2018) A Randomized Controlled Feasibility Trial in Behavioral Weight Management for Underserved Postpartum African American Women: The RENEW Study. Prev Chronic Dis 15:E77
DiTommaso, Tia; Cole, Julie M; Cassereau, Luke et al. (2018) Cell engineering with microfluidic squeezing preserves functionality of primary immune cells in vivo. Proc Natl Acad Sci U S A 115:E10907-E10914
Shi, Chao; Uda, Yuhei; Dedic, Christopher et al. (2018) Carbonic anhydrase III protects osteocytes from oxidative stress. FASEB J 32:440-452
Saitz, Richard; Mesic, Aldina; Ventura, Alicia S et al. (2018) Alcohol Consumption and Bone Mineral Density in People with HIV and Substance Use Disorder: A Prospective Cohort Study. Alcohol Clin Exp Res :
Alshenibr, Weam; Tashkandi, Mustafa M; Alsaqer, Saqer F et al. (2017) Anabolic role of lysyl oxidase like-2 in cartilage of knee and temporomandibular joints with osteoarthritis. Arthritis Res Ther 19:179
Cheong, Fei-Ying; Gower, Adam C; Farber, Harrison W (2017) Changes in gene expression profiles in patients with pulmonary arterial hypertension associated with scleroderma treated with tadalafil. Semin Arthritis Rheum 46:465-472
Arvanitis, Marios; Koch, Clarissa M; Chan, Gloria G et al. (2017) Identification of Transthyretin Cardiac Amyloidosis Using Serum Retinol-Binding Protein 4 and a Clinical Prediction Model. JAMA Cardiol 2:305-313
Ko, Darae; Rahman, Faisal; Martins, Maria A P et al. (2017) Atrial fibrillation in women: treatment. Nat Rev Cardiol 14:113-124

Showing the most recent 10 out of 41 publications